Hi Simons77,
dont want to be picky but, they (Glory) should get the homework straight before posting. Our company name is NEUREN not Neuron.
2nd, we all should not be blind-sided that one day a better therapy will come to market, thats the normal progression of things in the best case scenario. What is important to consider is timing and the lead time Acadia/NeurEn has in terms of setting up the relationships & infrastructure required.
Enjoy the ride with NEUREN.
Neuren Media and Analyst Coverage, page-876
-
- There are more pages in this discussion • 355 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |